Arizona Outsourcing Facility Warned for Misbranded, Adulterated Products

By Sam | September 26, 2018

The FDA slapped Phoenix-based outsourcing facility Atlas Pharmaceuticals with a warning letter for adulterated and misbranded drug products as well as numerous CGMP violations stemming from an inspection carried out in August and September 2017.
Source: Drug Industry Daily

Posted in Drug Industry Daily